Gaudium IVF and Women Health Limited has issued a regulatory disclosure intimation regarding an upcoming board meeting scheduled for Thursday, August 13, 2026. The primary purpose of the board meeting is to consider and approve the unaudited standalone and consolidated financial results of the company for the quarter ended June 30, 2026 (Q1 FY2027).
The board will also take on record the auditor's limited review report on these financial results, which will be issued by the statutory auditors of the company. The outcome of the board meeting, including the financial results and the auditor's limited review report, will be submitted to the stock exchanges in accordance with SEBI Listing Regulations.
Additionally, the company confirms that the trading window for dealing in the company's securities remains closed for designated persons and their immediate relatives. The trading window closure began on Wednesday, July 01, 2026, as previously communicated in the company's letter dated June 26, 2026. The window will remain closed until 48 hours after the declaration of the financial results.
This trading restriction is implemented pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and in compliance with the company's internal Code of Conduct and Fair Disclosure Code.
The disclosure was made under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and will be hosted on the company's website at https://www.gaudiumivfcentre.com.